Abstract
This study aims at detecting the level of BRCA1 protein as a marker of breast cancer in Iraqi women previously suffering from type 2 diabetes mellitus. The study includes: 80 participants they were divided into three subgroups based on drugs strategy and duration of disease, with ages (40–70) years. Blood samples were collected from Ibn AL-Bitar Hospital in Baghdad / Iraq between the period from November 2022 to February 2023. Some biochemical parameters were measured for all study groups, which include: -Fasting blood sugar (FBS) and Lipid profile, which were measured by enzymatic oxidation method. Using an enzymatic process, Insulin levels and Insulin-like Growth Factors (IGF-1) and Estrogen-receptor-alpha (ERα) levels, and Breast Cancer Susceptibility Protein1(BRCA-1) were measured via an ELISA. Glycated Hemoglobin (HbA1c) level was measured with a sandwich-immunodetection method. Finally, Homeostasis model assessment-insulin resistance (HOMA-IR) was calculated according to the specific formula. The result showed that the P-value for the comparison of groups were not significant for FBS, HbA1c, and lipid profile, while BRCA1, ERα, Insulin, IGF-1, and HOMA IR showed significance with P-value of 0.0001. The main finding is that patients taking metformin only less than one year which contributed to increase the level of BRCA1. There is a positive association between BRAC1 level with ERα, insulin, and IGF-1 levels. According to ROC-analysis, BRCA1 showed high sensitivity and specificity. We conclude that BRCA1protin is a good parameter to predict the incidence of breast cancer in women with type 2 diabetes and metformin increases the concentration of BRCA1-portien.
Keywords
BRCA1 protein, Breast cancer, ERα, Metformin, Type 2 diabetes mellitus
Subject Area
Chemistry
Article Type
Article
First Page
2924
Last Page
2932
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite this Article
Hassan, Hanan Hamed and ullah, Perry Habeb Saif
(2025)
"Impact of Metformin on BRCA1 Expression and Breast Cancer Risk in T2DM Patients,"
Baghdad Science Journal: Vol. 22:
Iss.
9, Article 9.
DOI: https://doi.org/10.21123/2411-7986.5050